bpc-157 and mots-c Peptides Archives Peptide Therapy in Tampa |
Description
Song et al., 2019)
Commonly used in fatigue and recovery states
Both Pfizer and Moderna have done booster studies, and we know that Pfizer has submitted the results of the booster trial to the FDA, but we dont yet know what those results say, but we do know those studies were conducted in areas of the US where the Delta variant was gaining hold
J Pharmacol Sci 95: 1926
The scheduled PCAC review on July 23, 2026, will be a defining moment not just for BPC-157, but for the broader peptide therapy industry
